Validation of Clinical Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ERCP
- Sponsor
- Changhai Hospital
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Duration of ERCP treatment
- Last Updated
- 8 years ago
Overview
Brief Summary
Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.
Detailed Description
Investigators recently developed a device named additioned Endoscopy. The purpose of current clinical trial is to evaluate the use of additioned endoscopy in ERCP treatment, specifically in shortening the duration of ERCP operation and lowering incidence of complications.
Investigators
Xiangyu Kong
Doctor of gastroenterology department
Changhai Hospital
Eligibility Criteria
Inclusion Criteria
- •People who are indicated to ERCP treatment.
Exclusion Criteria
- •People who are not suitable for ERCP treatment.
Outcomes
Primary Outcomes
Duration of ERCP treatment
Time Frame: Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient
To test if additioned endoscopy will have impact on duration of ERCP treatment
Secondary Outcomes
- complications of ERCP treatment(up to 1 month after ERCP completion)